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Autophagy is a crucial and physiological process for cell survival from yeast to mammals, including 
protozoan parasites. Toxoplasma gondii, an intracellular parasite, typically exploits autophagic 
machinery of host cell; however host cell upregulates autophagy to combat the infection. Herein we 
tested the efficacy of Rottlerin, a natural polyphenol with autophagic promoting properties, against 
Toxoplasma infection on the chorioncarcinoma-derived cell line BeWo. We found that Rottlerin, at 
sub-toxic doses, induced morphological and biochemical alterations associated with autophagy and 
decreased Toxoplasma growth in infected cells. Although autophagy was synergically promoted by 
Toxoplasma infection in combination with Rottlerin treatment, the use of the autophagy inhibitor 
chloroquine revealed that Rottlerin anti-parasitic effect was largely autophagy-independent and likely 
mediated by the converging inhibitory effect of Rottlerin and Toxoplasma in host protein translation, 
mediated by mTOR inhibition and eIF2α phosphorylation. Both events, which on one hand could 
explain the additive effect on autophagy induction, on the other hand led to inhibition of protein 
synthesis, thereby depriving Toxoplasma of metabolically essential components for multiplication. 
We suggest that modulation of the competition between pathogen requirement and host cell defense 
might be an attractive, novel therapeutic approach against Toxoplasma infection and encourage the 
development of Rottlerin-based new therapeutic formulations.
Autophagy is an evolutionary conserved process of cellular degradation that is crucial for cell survival, differ-
entiation and development from yeast to mammals, including protozoan parasites1. The autophagic process is 
controlled by several AuTophagy Genes (ATGs) through a multi-step mechanism that includes induction, cargo 
recognition, autophagosome formation/fusion with lysosomes and cargo digestion followed by release of the 
degradation products2. Autophagy is constitutively active on a basal level helping to sustain cellular functions, 
but it can be strongly induced in response to a multitude of stimuli, such as nutrients deprivation, hypoxia and 
pathogen infection (xenophagy), to name but a few. Although this process can be seen as a survival mechanism 
to deal with nutrient limitation, the prolonged and intense activation of autophagy can be lethal, because of 
self-degradation of essential cellular components3. Thus, autophagy can be a cell survival mechanism in certain 
circumstances, but a mediator of cell death in others. Autophagy is indeed a type of programmed cell death (Type 
II death) that has a distinct progression from that of the Type I apoptotic death and is particularly relevant in 
those cells where the apoptotic machinery is compromised, such as in certain cancer cells4, 5 or in protozoa, where 
a typical apoptosis has not been universally demonstrated6.
Toxoplasma gondii is an intracellular protozoan parasite that infects virtually any type of nucleated cells from 
a wide range of warm-blooded vertebrates, including humans. The prevalence of toxoplasmosis varies greatly 
around the world, it has been estimated that approximately 30% of human population worldwide is chronically 
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infected with T. gondii7. Primary infection in adults results in mild or nonspecific symptoms8. However in immu-
nocompromised individuals, primary infection or reactivation of chronic infection can cause fatal toxoplasmi-
cencephalitis, myocarditis and pneumonitis9. In addition, toxoplasmosis is associated with severe congenital 
defects when primary infection is acquired during pregnancy, especially during the first trimester of pregnancy8.
Moreover, because Toxoplasma is an obligated intracellular pathogen, the autophagic process switched on by 
the host cell (xenophagy) might be determinant for the parasite fate. In fact, while T. gondii typically exploits the 
autophagic machinery of the host cell to its own advantage10, the host cell upregulates autophagy to combat the 
infection. It follows that there might be a threshold, non-deadly for the host cell, beyond which autophagy leads 
to parasite death. Modulation of the competition between pathogen requirement and host cell defense could be 
therefore an attractive and novel therapeutic approach.
Following this hypothesis, in the current study, we tried to perform a precise autophagy-targeted approach, 
based on the known autophagy promoting effects of Rottlerin4, 10, 11.
As recently reported, Rottlerin induced autophagy through inhibition of mTORC1, a negative regulator of 
autophagy5. Importantly, mTORC1 is also a key player in the control of protein synthesis, which, conversely, 
is stimulated. Indeed, the initiation step of mRNA translation is commenced by the binding of the eukaryotic 
translation initiation factor 4 F (eIF4F) complex to the cap-structure of mRNA. eIF4E is regulated by 4E-BP, 
whose phosphorylation by mTORC1 causes the release of free eIF4E that will then initiate protein synthesis. Thus, 
mTORC1 inhibition results in both autophagy induction and translational arrest12.
Rottlerin is a natural polyphenol isolated from Mallotus philippinensis, an ancient traditional Indian medicinal 
plant in Ayurvedic Medicine System, mainly known for its anthelminthic activity13, 14. Rottlerin, however, has 
potential beneficial applications in a variety of other ailments, being an antioxidant15, anti-inflammatory16, 17, 
antiallergic17, antibacterial18, 19 and anticancer compound20. Rottlerin is a very versatile substance that has been 
used for decades as a selective PKCδ inhibitor21 though it is now clear that Rottlerin also inhibits other enzymes22 
and acts as a mitochondrial uncoupler23.
Given the pleiotropic properties of Rottlerin, in particular its autophagy inducing ability and the importance 
of T. gondii infection during pregnancy8, the aim of the current study was to test the efficacy of Rottlerin against 
the parasite, in the trophoblast-like cell line BeWo, the most extensively used cellular in vitro model for villous 
trophoblast studies.
Autophagy is physiologically involved in normal placentation24 and recent studies suggest that autophagy 
in trophoblasts has primarily an adaptive role25. An increase in autophagy flux is indeed associated with cyto-
protective mechanisms of the trophoblast cells against micro environmental challenges24, 26. Hence, autophagy 
induction is expected to be well tolerated by BeWo cells.
However, because of the several, potentially harmful, Rottlerin effects, the drug needs to be used with caution. 
Then, the main challenge of this work was to individuate the optimal dose that is not toxic for the host cell, but is 
lethal for the parasite.
Results
BeWo cells viability. The effect of Rottlerin on viability of BeWo cells was evaluated by Trypan Blue exclu-
sion assay. As reported in Fig. 1, no difference in cell viability with respect to control (vehicle-treated cultures), 
was observed when BeWo cells were treated with Rottlerin at concentrations from 0.5 to 5 µM, neither at 24 nor 
at 48 hours. On the other hand, significant decrease of cell viability was observed at the concentrations of 10 
and 20 µM at both 24 and 48 hours (Fig. 1). Specifically, cell viability was reduced to around 60% after 24 hours 
of 10 µM Rottlerin treatments and to less than 50% after 48 hours. The decrease was more marked with 20 µM 
Rottlerin, being cell viability reduced to less than 50% already after 24 hours of incubation, and to around 30% 
after 48 hours. Based on these data we performed subsequent experiments using Rottlerin at concentrations of 
0.5, 1, 2 and 5 µM.
Figure 1. Effect of Rottlerin treatment on BeWo cells viability. BeWo cells were treated for 24 and 48 hours 
with increasing concentrations of Rottlerin (0.5 µM–20 µM) and cell viability was evaluated by direct cell 
counting (Trypan Blue). Data are expressed as a percentage of control (vehicle-treated)cultures and reported 
as mean ± SEM. The results represent four independent experiments performed in quadruplicate for each data 
point. *p < 0.05.
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Rottlerin decreases T. gondii growth in BeWo cells. The effect of Rottlerin on parasite growth was 
evaluated in BeWo cells infected for 3 hours and then treated with the compound for 24 and 48 hours. Our results 
showed that increasing concentrations of Rottlerin resulted in significant inhibition of tachyzoites growth from 
around 50% (0.5 µM Rottlerin) to 85% (5 µM Rottlerin) as respect to vehicle-treated cell cultures after 24 as well 
as after 48 hours cultures (Fig. 2). Interestingly, while a significant increase was observed in tachyzoites number 
from 24 to 48 hours in 0.5, 1 and 2 µM Rottlerin-treated cultures, no evidence of parasite growth was found in the 
same time interval at the dose of 5 µM (Fig. 2). Therefore, this dose was chosen for the subsequent experiments. 
The indices of infection and parasite replication were determined in BeWo after 24 h of infection with or without 
Rottlerin treatment by a direct observation under a light microscope (see Supplementary Figure S1). Results 
showed a significant decrease of infected cells as well as a significant decrease in the number of parasites per cells 
(Supplementary Figure S1).
Toxoplasma gondii and Rottlerin are able to induce morphological and biochemical altera-
tions associated with autophagy in BeWo Cells. Due to the well-known properties of Rottlerin as 
a pro-autophagic drug, we performed morphological and biochemical analysis to investigate on the significant 
reduction of parasites number observed in the current study.
Electron microscopy (Fig. 3 left panel) reveled that BeWo cells untreated and not infected showed typical 
morphological characteristics with nuclear decondensed chromatin and evident nucleolus, cytoplasm containing 
mitochondria, polyribosomes and granular endoplasmic reticulum (Fig. 3A–C). When BeWo cells were treated 
with 5 µM Rottlerin for 24 hours, morphological changes were observed with the occurrence of cytoplasmic vac-
uoles and multivesicular bodies (Fig. 3D–F) but no signs of nuclear alterations were visible (Fig. 3D). BeWo cells 
infected with T. gondii showed a slight expansion of the rough endoplasmic reticulum (Fig. 3G–I). Of note, when 
BeWo cells were infected with T. gondii and treated with 5 µM Rottlerin for 24 hours, dramatic morphological 
alterations, with many cytoplasmic vacuoles as well as numerous multivesicular bodies, were observed (Fig. 3L,M). 
Of note, the presence of double membraned vacuoles indicates their autophagosomal nature (Fig. 3N and O), 
which was confirmed by the immunoblotting analysis of cell lysates showing an increase in the lipidated form of 
LC3 (LC3II) and a reduction/degradation of p62 protein, hallmarks of autophagic flux, both in Rottlerin treated 
and infected BeWo cells (Fig. 3P and Q). Importantly, as it can be appreciated in Fig. 3Q, the expression of p62 
was more markedly reduced and LC3II enhanced when BeWo cells were T. gondii infected and then treated with 
5 µM Rottlerin.
At the same time, we found that BeWo cell viability was unaffected by the infection and 5 µM Rottlerin treat-
ment or a combination of the two (Fig. 3S). This result, along with the lack of nuclear alterations (Fig. 3D) and 
PARP cleavage (Fig. 3R), excludes the occurrence of apoptotic cell death at this Rottlerin dose.
Beclin-1 and mTORC1 involvement in Rottlerin- and Toxoplasma-triggered autophagy. The 
two main pathways eventually involved in the autophagy process, Beclin-1, the mammalian orthologue of yeast 
Atg6/Vps30 with a key role in autophagosome formation27 and the mTORC1 cascade28 were investigated. As 
shown in Fig. 4A, no change (induction) of Beclin-1 was observed both in the Rottlerin-treated and in the T. 
gondii -infected cells. Conversely, Rottlerin treatment, but not T. gondii infection, decreased the levels of the phos-
phorylated forms of 4EBP-1 isoforms (Fig. 4B), indicating that, in agreement with previous findings5, Rottlerin 
induced autophagy via inhibition of mTORC1 kinase activity. Given the independence from both Beclin-1 and 
mTORC1 in T. gondii-driven autophagy in the host cell, we presumed the involvement of the endoplasmic reticu-
lum (ER) stress/eIF2α axis as a likely mechanism29. The results from Western blotting analysis of BeWo cell lysates 
after infection, indicated the ER stress-stimulated kinase, PERK, was activated, since eIF2α phosphorylation (a 
marker of ER stress) increased (Fig. 4C). Moreover, in agreement with the literature30, we found that Rottlerin 
alone was able to trigger ER stress and to increase eIF2α phosphorylation.
Figure 2. Effect of Rottlerin treatment on T. gondii proliferation. BeWo cells were infected with T. gondii (host 
cell: tachyzoites, 1:5) for 3 hours then treated with increasing concentrations of Rottlerin (0.5 µM–5 µM). T. 
gondii proliferation was evaluated after 24 and 48 hours by a colorimetric microtiter assay using β-galactosidase-
expressing tachyzoites. Data were expressed as mean ± SEM of the number tachyzoites calculated in relation to 
a reference curve and are representative of three independent experiments performed in triplicate. *p < 0.0001: 
Rottlerin -treated vs control-vehicle cultures at 24 hours; #p < 0.01: Rottlerin -treated vs control-vehicle cultures 
at 48 hours; §p < 0.05: Rottlerin-treated cultures at 24 hours vs 48 hours.
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Role of host autophagy in T. gondii proliferative potential. To evaluate the role of autophagy in the 
Rottlerin anti-parasitic action, the autophagy inhibitor CQ, which blocks the late acidification steps of the pro-
cess, was used. As shown in Fig. 5, CQ failed to prevent the Rottlerin inhibition of parasite replication, indicating 
that, although the autophagic pathway was clearly stimulated, autophagy was not responsible for the Rottlerin 
protective mechanism against infection. Moreover, in agreement with the notion that T. gondii usually exploits 
the autophagic machinery of the host cell for survival purposes, CQ alone decreased parasite growth inside the 
host cell.
Discussion
Up to now, an effective treatment against T. gondii, with no toxicity for the host, has not been yet discovered. In 
fact, most of the current therapies exhibit a high degree of toxicity8, 31.
The recommended treatment adopted for toxoplasmosis is the combination of the antibiotics sulfadiazine, 
pyrimethamine and folinic acid or spiramycin. However, this regimen is commonly associated with many adverse 
effects, including teratogenic effects in the first trimester of pregnancy32. Thus, researchers are encouraged to 
disclose new, less toxic drugs that actively combat/prevent T. gondii infection.
In the current study, BeWo cells were used as an in vitro model of human trophoblast. Our group for many 
years is engaged in the study of congenital toxoplasmosis focusing the research on the placenta33, 34. Many in vitro 
models have been established for human placental trophoblast studies, among which cell lines, including BeWo 
cells, are widely used and particularly advantageous in terms of reproducibility to evaluate the net effect of thera-
peutic agents on laboratory challenge tests with pathogens35, 36. We found that Rottlerin sub-toxic concentrations 
for host cells are able to combat T. gondii infection in BeWo cells significantly and dose dependently.
In agreement with the notion that Rottlerin is an autophagy inducer, we have shown that Rottlerin alone, 
even at doses not affecting cell viability, can induce autophagy also in BeWo cells. As previously found in MCF-7 
cells, also in BeWo cells Rottlerin induced autophagy via mTORC1 inhibition and independently from Beclin-15. 
Autophagy is a natural defense against parasites and, indeed, we found enhanced cytoplasmic vacuolization 
and stimulated autophagic flux in infected cells. However, T. gondii -induced autophagy was both Beclin-1 and 
mTORC1-independent, indicating that the two autophagy inducers engage different pathways. Recent studies 
by Sellek et al.37 reported that the IFNγ-mediated T. gondii control in human cells occurred through a mech-
anism different from both canonical autophagy (Beclin 1-independent) and xenophagy. Despite the different 
Figure 3. T. gondii and Rottlerin induce morphological and biochemical alterations associated with autophagy 
in BeWo Cells. Left panel: control-vehicle treated cultures (A,B and C); 5 µM Rottlerin-treated cultures (D,E 
and F); T. gondii infected cultures (G,H and I); T. gondii infected and 5 µM Rottlerin treated cultured (L,M,N 
and O). Arrows: cytoplasmic vacuoles; star: T. gondii; double arrow head: expansion of the rough endoplasmic 
reticulum; arrow head: double membraned vacuoles (P and Q): representative western blot and densitometric 
analysis performed on three independent experiments of LC3I/II (P) and p62 (Q) proteins in BeWo cells after 
infection and treatment with 5 µM Rottlerin. *p < 0.05; #p < 0.01. (R): representative western blot of three 
independent experiments of PARP proteins in BeWo cells after infection and treatment with 5 µM Rottlerin. 
(S): viability of BeWo cells after infection and treatment with 5 µM Rottlerin (Rt). (A) Bar = 5 µm; (B,C,F and I), 
Bar = 500 nm; (D,L and M), Bar = 2 µm; (E,G,H), Bar = 1 µm.
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experimental model, Sellek’s and our results converge on a non-canonical (Beclin 1-independent) autophagic-like 
pathway triggered by T. gondii in host cells.
Our results are also in agreement with the earlier Wang’s study38 which demonstrated that T. gondii-induced 
autophagy in host cells was mTOR-independent and somehow dependent on a calcium-sensitive step.
Figure 4. T. gondii and Rottlerin engage different autophagic pathways. Representative western blot and 
densitometric analysis, performed on three independent experiments, of Beclin-1 (A), phosphorylated forms 
of 4EBP-1 (B) and phosphorylated eIF2α (C) in BeWo cells after infection and treatment with 5 µM Rottlerin. 
*p < 0.05.
Figure 5. Autophagy is not responsible for the Rottlerin anti parasitic action. BeWo cells were infected with 
T. gondii (host cell: tachyzoites, 1:5) for 3 hours then treated 5 µM Rottlerin plus increasing concentrations of 
CQ (5, 10, 25 µM). T. gondii proliferation was evaluated as described in Fig. 2 after 24 and 48 hours *p < 0.0001. 
Data were expressed as mean ± SEM of the number of tachyzoites calculated in relation to a reference curve and 
are representative of three independent experiments performed in quintuplicate.
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Although further work is needed to identify the exact mechanism of T. gondii-induced host autophagy, the 
slight expansion of the endoplasmic reticulum (ER) observed in infected BeWo cells (Fig. 3G–I), pointed towards 
a possible T. gondii-induced ER stress/eIF2 kinase (PERK)-dependent autophagic pathway. Indeed, eIF2 kinases 
can promote autophagy, via phospho-eIF2α-ATF4, by inducing transcription of a set of autophagy genes29.
The association between the parasitophorous vacuoles (PV) and the host ER, which could be a source of 
membrane for the enlargement of the PV, dates back to 199739 and it has been confirmed in more recent studies 
showing, by electron microscopy, that PVs were surrounded by ER40. It is very possible that this tight interaction 
could led to ER stress and trigger the so called unfolding protein response in the host. Consistently, recent studies 
reported that apoptosis of mice trophoblasts and neural stem cells infected with T. gondii was triggered by ER 
stress41, 42. Although no (apoptotic) death was observed in infected BeWo cells, the results from Western blotting 
analysis of cell lysates after infection showed increased eIF2α phosphorylation, indicating the activation of the ER 
stress-stimulated kinase, PERK. We assumed that this could be the underlying mechanism of T. gondii-triggered 
host autophagy.
Accordingly to the double stimulation (by Rottlerin and infection-induced ER stress and Rottlerin-inhibited 
mTORC1), we observed an exacerbated autophagic response, both at the microscopic (TEM) and the biochemical 
(Western blotting of LC3I/II and p62) level, in infected cells after Rottlerin exposure.
However, the over-stimulation of autophagy was not the mechanism by which Rottlerin decreased parasite 
replication, since the drug had superimposable effects in the absence or in the presence of the autophagy inhibitor 
CQ. Moreover, consistently with the notion that T. gondii usually exploits the autophagic machinery of the host 
cell for survival purposes, we observed that CQ alone hampered parasite growth inside the host cell. However, 
given the general ability of CQ to inhibit organelles acidification, we cannot exclude that it could have a direct 
effect on parasite as well. Moreover, because CQ does not block the formation of autophagosoma, it is possible, 
in theory, that this could be sufficient to arrest parasite replication even in the absence of a complete autophagic 
flux. However, because Rottlerin and CQ have not an additive effect, this eventuality can be ruled out. At the 
same time, the lack of synergism/antagonism between Rottlerin and CQ confirms the irrelevance of autophagy 
induction in the Rottlerin outcome.
Overall, these findings suggest that a novel mechanism, alternative to autophagy, are responsible for the 
Rottlerin protective effect against T. gondii infection in BeWo cells; such a mechanism could be host protein 
synthesis curtailing (Fig. 6).
Indeed, in addition to mTORC1, which is a regulator of cap-dependent mRNA translation, phosphorylation 
of eukaryote initiation factor 2a (eIF2a) on serine 51 by ER stress-activated kinases potently inhibits the initiation 
of protein translation. It is well known that T. gondii actively appropriates numerous host cell processes and sig-
nificant changes in host cell transcripts occur during the course of the infection, indicating that the contribution 
of host transcriptional/translational activities is essential for successful infection43.
Figure 6. Schematic representation of the Rottlerin action against Toxoplasma gondii infection. Rottlerin 
inhibited the mTORC1/4EBP-1 axis and, synergically with T. gondii, induced eIF2α phosphorylation. Both 
events led to autophagy induction and inhibition of protein synthesis.
www.nature.com/scientificreports/
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The inhibition of protein translation, that inevitably occurs in concomitance with autophagy induction, 
appeared to be a very effective process in reducing parasites proliferation, especially when synergically promoted 
by T. gondii infection, via ER stress/eIF2α, in combination with Rottlerin, via mTORC1/4EBP.
In closing, the results of the current study encourage the development of Rottlerin-based new therapeutic for-
mulations against T. gondii infection for which a limited number of effective and safe drugs are currently available. 
Particularly, the results here obtained might be useful to combat and/or prevent the possible severe consequences 
for the fetus by maternal infection during pregnancy.
Materials and Methods
Cell culture. The choriocarcinoma-derived BeWo cell line, used as experimental model of trophoblast cells, 
was obtained from the American Type Culture Collection, (Manassas, VA, USA). Cells were grown in RPMI 1640 
medium (Cultilab, Campinas, SP, Brazil) containing 10% fetal bovine serum (FBS) (Cultilab) supplemented with 
25 mM HEPES, 2 mM L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin (Sigma Chemical Co., St 
Louis, MO, USA). Cells were routinely cultured in 75 cm2 vented flasks in a humidified 5% CO2–95% air atmos-
phere at 37 °C until 70–80% confluence.
Rottlerin. Rottlerin (Sigma Chemical Co.) was dissolved in dimethyl sulfoxide (DMSO; vehicle) to a con-
centration of 20 mM (stock solution). Stock solution was freshly diluted in culture medium and concentrations 
ranging from 0.5–20 µM were used for the treatments.
Cell viability. Cell viability was assessed by Trypan blue exclusion assay. Briefly, BeWo cells were seeded in 
24-well plates at 5 × 104/mL in RPMI 1640 (supplemented as above described) and 10% FBS. The day after, the 
medium was substituted with fresh RPMI 1640 with 2% of FBS containing increasing concentrations of Rottlerin 
(0.5, 1, 2, 5, 10 and 20 µM) or vehicle as control. The cultures were incubated for 24 and 48 hours. Cell viabil-
ity was assessed also after cell infection. Briefly, BeWo cells were infected and treated with Rottlerin (5 µM) for 
24 hours as described thereafter. The number of viable cells was evaluated by detaching with trypsin solution 
(0.05% trypsin–0.02% sodium EDTA) and using the Countess™ automated cell counter (Invitrogen, Carlsbad, 
CA, USA), which employs the standard Trypan blue technique. Four replicate counts were determined at each 
time point. The viability was presented as a percentage of control (vehicle-treated cells).
Parasite. Tachyzoites of T. gondii 2F1 strain derived from the RH strain and gently provided by Dr. Vern 
Carruthers, Medical School of Michigan University (USA) were used in the current study. These parasites, which 
constitutively express cytoplasmic β-galactosidase, were propagated in BeWo cells maintained in RPMI 1640 
medium supplemented with penicillin, streptomycin, and 2% FBS at 37 °C and 5% CO2.
Tachyzoites were harvested by scraping off the BeWo monolayer within 3 days of infection, passed through 
a 26-gauge needle to lyse any remaining intact host cells and finally centrifuged at 720 × g for 5 minutes to pellet 
the parasite. Parasites, suspended in RPMI 1640 medium, were stained with 0.4% Trypan blue and counted in a 
hemocytometric chamber for infection experiments.
Infection of BeWo cells by T. gondii and treatments. BeWo cells were cultured in 96-well plates 
(2 × 104 cells/well/200 µL) in RPMI 1640 with 10% FBS at 37 °C and 5% CO2 overnight. Next, BeWo cells were 
infected with T. gondii tachyzoites (2F1 strain) at levels of 5 parasites per cell (5:1). After a 3 hour-infection period, 
the non-adherent parasites were removed along with the supernatant. The infected cells were washed twice with 
warm medium, the plates were refilled with fresh medium at 2% of FBS containing the treatment (Rottlerin at 0.5, 
1, 2 and 5 µM), and incubated for 24 and 48 hours at 37 °C. In a set of experiments, the infected cells were treated 
with 5 µM Rottlerin plus 5, 10 and 25 µM chloroquine (CQ) (Sigma Aldrich, St. Louis, MO USA).
T. gondii intracellular proliferation was evaluated using a colorimetric β-galactosidase assay as previously 
described44. T. gondii intracellular proliferation data were expressed as the number of tachyzoites calculated in 
relation to the standard curve of 2F1 strain tachyzoites ranging from 1 × 106 to 15.625 × 103 parasites.
Electron Microscopy. BeWo cells, under the various treatments, were pelleted and fixed overnight with 
2.5% glutaraldehyde, 2% paraformaldehyde diluted in 0.1 M phosphate buffered saline (PBS), pH 7.2, washed 
three times with PBS and post-fixed for 1 hour in 1% OsO4, dehydrated in increasing concentrations of ethanol 
and embedded in Epon (Sigma and Co.). Ultrathin sections were stained with uranyl acetate and lead citrate and 
finally examined in a Zeiss EM 109 transmission electron microscope (Zeiss, Jena, Germany).
Western blotting. After treatments, BeWo were washed with PBS and then cryolysed (three freeze-thaw 
cycles) with RIPA [50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 1% (w/v) sodium deoxycholate, and 0.1% 
(w/v) sodium dodecyl sulfate (SDS), pH 7.5] containing a cocktail of protease and phosphatase inhibitors. Cell 
debris was pelleted by centrifugation at 14.000 × g for 15 min. The supernatants were transferred to new tubes, 
and the protein concentration was measured using the Bradford assay.
Equal amounts of protein samples were resolved on 10%, SDS–polyacrylamide gels under reducing con-
dition. Proteins were electro-transferred onto PVDF membranes and then blocked in 4% non-fat dry milk in 
Tris-buffered saline pH 7.2 (TBS) containing 0.1% Tween 20 for 2 hours at room temperature. Then, the blots 
were probed with polyclonal antibodies anti human LC3I/II, p4EBP-1, Beclin 1, peIF2α and PARP (Cell Signaling 
Technology, Boston, MA USA), SQSTM1/p62 and β-actin (Santa Cruz Biotechnology; Santa Cruz, CA) at dilu-
tion of 1:1000 overnight at 4 °C. After washing, appropriate horseradish peroxidase-conjugated IgG was added for 
2 hours at room temperature. The blots were then developed by the ECL Detection Reagents and then exposed on 
photographic film, according to the manufacturer’s instructions or digitalized with CHEMI DOC Quantity One 
program (BioRad Microscience).
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Statistical analysis. All experiments were repeated at least three times. The data were analyzed with 
GraphPad Prism 4 using one-way ANOVA and the Bonferroni multiple comparison post-test or Student’s t-test 
when appropriate. p < 0.05 was considered to be statistically significant.
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